This collaboration will expand OPM's 3D-printed PEKK OsteoFab-Rx implants across the UK.
Oxford Performance Materials, Inc. has announced an exclusive distribution partnership with Sovereign Medical Ltd. a prominent UK-based medical distribution organization. This exclusive collaboration will expand the reach of OPM’s unique 3D-printed PEKK OsteoFab-Rx personalized implant product line across the United Kingdom for lower & upper extremity, oncology, and trauma applications.
Like the 3DP OsteoFab technology for patient-matched CMF and standard-sized spinal implants, OPM’s personalized OsteoFab-Rx devices provide the following key benefits: metal-free & bone-like mechanics, biocompatability, inherent bacteriostatic properties, osseointegration, and modifiability in the O.R. Adoption of the OsteoFab-Rx line in the U.S. has been swift, with case volume increasing four-fold in 2024 as surgeons in the U.S. incorporate OPM’s personalized solutions as the metal-free option for their practices.
Under this new agreement, Sovereign Medical will leverage its extensive regulatory expertise and established relationships with UK medical centers to facilitate the import and distribution of OPM’s OsteoFab-Rx products throughout the United Kingdom. This partnership will ensure that OPM’s cutting-edge medical solutions are accessible to a broader patient population, enhancing the quality of care and improving patient outcomes.
Look for additional announcements of international distribution partnerships for OPM’s OsteoFab technology in the months to come.
For more information, visit oxfordpm.com.
